Navigation Links
Medarex Announces Completion of Sale of Shares in Genmab A/S
Date:2/1/2008

PRINCETON, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that it has completed the sale of approximately 2.5 million shares of Genmab A/S which stock is traded on the Copenhagen Stock Exchange. The trade is expected to settle on February 1, 2008. Medarex expects to receive approximately $151.8 million (USD) in net proceeds from the sale. The sale of Genmab shares reduces Medarex's ownership in Genmab to approximately 5.1 percent.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 30 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase III clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its Web site at http://www.medarex.com.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
2. Medarex Announces Election of Marc Rubin as New Board Member
3. Medarex to Present at the UBS Global Life Sciences Conference
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
6. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
7. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
8. Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application
9. Rigel Announces Pricing of Public Offering of Common Stock
10. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
11. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., This release is available in German . ,...cation cards: RFID tags (Radio Frequency Identific...ryday life. They make it possible to label objects... frequency. The appropriate scanner can read and p...ls can be affixed to goods under production condit...
(Date:11/24/2009)..., The New York investment...Ltd (ASX:NEU) has agreed an AU$6.7 mil convertible...investor. The private placement was arranged by KT...d advisor. , New York (PR... investment bank KTA Capital, LLC ("KTA Capit...
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-F...yannouncedthatithasreceivednoticefrom,theNasdaqSto...,suspendedasofNovember30,2009andaForm25-NSEwillbef...illremovedeCODE,scommonstock,fromlistingonNasdaq,u...lificationsPanel.Thecompanyhasfiledsuchanappeal,wh...
(Date:11/24/2009)...,, REYKJAVIK,Iceland,November24/PRNewswire-F...yannouncedtheapprovalofallofits,"firstday"motionsb...he"BankruptcyCourt").deCODElastweekfiledavoluntary...ankruptcyCodewiththe,BankruptcyCourt. , Theor...tinue,tooperateitsbusinessduringtheChapter11procee...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
... Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) today ... accomplishments., For the second quarter ended J...loss of $7.4 million, or $0.18 per share, compared..., for the same period in 2007.,As of June 30, 2008...tments,of $64.3 million., Revenues for the second...
... Operating Earnings Down 6%, GAAP Operating Earnin...GAAP Diluted EPS Down 19%, PALO ALTO, Calif., Jul... third fiscal quarter 2008 revenues of,$244.4 mill...s of $227.1,million in the third quarter of fiscal...includes environmental, food and energy) and life ...
...uman Genome,Sciences, Inc. (Nasdaq: HGSI ) today ...o discuss its financial results for the quarter en...e disclosed on Wednesday, July 30,2008, after the ...m.com/cgi-bin/prnh/20080416/HGSLOGO ), The confe... will be,held on Wednesday, July 30, 2008 at 5:00 ...
Other Biology Technology:Sangamo BioSciences Reports Second Quarter 2008 Financial Results 2Sangamo BioSciences Reports Second Quarter 2008 Financial Results 3Sangamo BioSciences Reports Second Quarter 2008 Financial Results 4Sangamo BioSciences Reports Second Quarter 2008 Financial Results 5Sangamo BioSciences Reports Second Quarter 2008 Financial Results 6Sangamo BioSciences Reports Second Quarter 2008 Financial Results 7Sangamo BioSciences Reports Second Quarter 2008 Financial Results 8Varian, Inc. Reports Third Quarter 2008 Results 2Varian, Inc. Reports Third Quarter 2008 Results 3Varian, Inc. Reports Third Quarter 2008 Results 4Varian, Inc. Reports Third Quarter 2008 Results 5Varian, Inc. Reports Third Quarter 2008 Results 6Varian, Inc. Reports Third Quarter 2008 Results 7Varian, Inc. Reports Third Quarter 2008 Results 8Varian, Inc. Reports Third Quarter 2008 Results 9Varian, Inc. Reports Third Quarter 2008 Results 10Varian, Inc. Reports Third Quarter 2008 Results 11Varian, Inc. Reports Third Quarter 2008 Results 12Varian, Inc. Reports Third Quarter 2008 Results 13Varian, Inc. Reports Third Quarter 2008 Results 14Varian, Inc. Reports Third Quarter 2008 Results 15Varian, Inc. Reports Third Quarter 2008 Results 16Varian, Inc. Reports Third Quarter 2008 Results 17Varian, Inc. Reports Third Quarter 2008 Results 18Varian, Inc. Reports Third Quarter 2008 Results 19Varian, Inc. Reports Third Quarter 2008 Results 20Varian, Inc. Reports Third Quarter 2008 Results 21Varian, Inc. Reports Third Quarter 2008 Results 22Varian, Inc. Reports Third Quarter 2008 Results 23Varian, Inc. Reports Third Quarter 2008 Results 24Varian, Inc. Reports Third Quarter 2008 Results 25Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results 2
(Date:11/23/2009)...RE, Calif. - By producing some of the highest reso...faces, scientists have a deeper understanding how ...research may lead to a new treatment for kidney st...ppears in the Nov. 23 online edition of the journa... , explores how peptides interact with mineral sur...
(Date:11/23/2009)...MINGHAM, Ala. A new study by University of Alabam...mass index (BMI) and co-existing medical condition...ival observed among African-Americans compared to ...s published online Nov. 23 in Cancer , a journal ...dicates that although BMI and co-morbidity are ind...
(Date:11/23/2009)...GN, Ill. Two new studies reveal in unprecedented ...ules to assemble new proteins and guide them towar...es used molecular dynamics flexible fitting (MDFF)...wo prominent molecular partners. , The first st...iences , concerns the intimate signaling between t...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Hot microbes cause groundwater cleanup rethink 9979 1Hot microbes cause groundwater cleanup rethink 9979 2Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 9975 1Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 9975 2Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 9975 3Symposium marks 20th anniversary of Theoretical and Computational Biophysics Group 9975 4New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 1New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 2New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 3New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 4New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 5New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 6
...lands: Consumers are five times more likely to ide...fic light nutrition labels than when labels presen...entage of the recommended daily nutrient intake ea...overnments are trying to improve the quality of nu...in supermarkets by adding labels to the front of f...
...NY) Inappropriate use of camphor-containing produ...seizures in young children, according to a new stu...dicine of Yeshiva University. The study, published...efforts to educate communities about the hazards o...camphor products. , Camphora naturally occurring ...
...of influenza infection severity have been identifi... find most of these markers, described in the open...the current swine-flu strain. , Jonathan Allen an...ratory, America, published their analysis identify...emic flu strains two weeks ago. They have since st...
Other Biology News:Consumers more likely to identify healthy food using traffic light nutrition labels 2Camphor-containing products may cause seizures in children 2
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Rabbit Anti-DDDDK Tag Antibody, Agarose Conjugated from MBL International
Goat Anti-FbxL7 Polyclonal Antibody, Unconjugated from GeneTex
Anti-PERK, phospho (Thr980) Antibody, Unconjugated from Cell Signaling Technology
Biology Products: